KWILP
ITCI

Kiwi Wealth Investments Limited Partnership’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,388
Closed -$1.07M – 273
2021
Q4 		$1.07M Buy
+20,388
New +$856K 0.05% 204

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's ITCI Position: Q1 2022 in Review

Kiwi Wealth Investments Limited Partnership sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2022, closing a stake of 20,388 shares — an estimated $1.07M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in ITCI in Q4 2021 and held it in 1 quarter. The position peaked at $1.07M in Q4 2021. 241 funds tracked by Wall St. Rank hold ITCI as of Q1 2022.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2022 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 20,388 Intra-Cellular Therapies Inc. shares in Q1 2022, an estimated $1.07M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Intra-Cellular Therapies Inc. in Q4 2021 and held it in 1 quarter.
  • Kiwi Wealth Investments Limited Partnership's Intra-Cellular Therapies Inc. position peaked at $1.07M in Q4 2021.
  • 241 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2022.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q1 2022, filed 17 May 2022.